查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953388

頸椎病診斷及治療市場－全球產業規模、佔有率、趨勢、機會及預測（按診斷、產品類型、通路、地區和競爭格局分類，2021-2031年）

Cervical Spondylosis Diagnosis And Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Product Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球頸椎病診斷和治療市場預計將從 2025 年的 64.4 億美元成長到 2031 年的 95.1 億美元，複合年成長率為 6.71%。

此領域涵蓋透過先進的影像技術和治療性介入，對頸椎退化性病變進行醫學識別和管理，以治療椎間盤和關節退化。成長的主要促進因素是全球人口快速老化以及生活方式因素導致的頸部疾病發病率上升，從而產生了對有效疼痛管理和復健護理的迫切需求。此外，早期發現以避免永久性神經損傷的重視也推動了市場擴張。根據全球肌肉骨骼健康聯盟（Global Alliance for Musculoskeletal Health）2024年報告，頸痛影響全球約2.03億人，由於人口結構變化，預計到2050年這一數字將達到2.69億。

市場概覽
預測期 2027-2031
市場規模：2025年 64.4億美元
市場規模：2031年 95.1億美元
複合年成長率：2026-2031年 6.71%
成長最快的細分市場 零售藥房
最大的市場 北美洲

儘管市場前景廣闊，但仍面臨諸多挑戰，包括先進診斷技術和外科手術的高成本，這限制了對成本敏感地區患者的就醫途徑。此外，開發中國家擇期脊椎手術報銷政策不足以及合格脊椎專科醫生短缺，往往會進一步加劇此經濟障礙。這些因素共同導致資源匱乏地區難以獲得高品質的治療方案，阻礙了市場滲透率的提高。

市場促進因素

全球老年人口的快速成長和預期壽命的延長正在推動市場發展，直接導致易患退化性脊椎疾病的患者數量增加。隨著老齡化，頸椎自然會磨損，導致椎間盤劣化和骨贅形成，這些都需要醫療干預。根據StatPearls Publishing於2025年5月發布的關於頸椎病的報告，該疾病被認為是老齡化的自然組成部分，65歲人群的患病率高達95%，預計治療需求將保持穩定和持續成長。聯合國於2024年7月發布的《2024年世界人口展望》報告進一步印證了這一趨勢。該報告預測，到2024年，65歲及以上人口將達到8.3億，到2054年將加倍，達到17億，這證實了患者群體規模的不斷擴大。

同時，診斷影像和微創脊椎手術技術的進步提高了治療的精準度和患者安全性，從而推動了市場成長。諸如機器人導航和先進的磁振造影技術等創新技術能夠實現精準干預，與傳統手術相比，顯著降低了手術風險和縮短了恢復時間。這使得越來越多的患者選擇接受以往被認為創傷過大的修復性手術。例如，2024年9月發表在《貝克爾脊椎評論》（Becker's Spine Review）上的報導指出，Globus Medical在第二季度的機器人設備安裝量同比成長了59%。這些進步透過促進尖端高科技解決方案的應用，改善了患者的治療效果，並推動了行業收入的成長。

市場挑戰

先進的診斷技術和手術干預的高昂費用是頸椎病診斷和治療市場發展的主要障礙。 MRI和CT掃描儀等影像設備以及脊椎移植和器械所需的大量資金，在價格敏感地區往往令人望而卻步。這種經濟負擔將患者群體限制在擁有雄厚私人資金或廣泛保險的個人，實際上將相當一部分需要治療頸椎退化性疾病的人排除在外。因此，高階治療方案主要集中在已開發經濟體，而低收入市場則面臨獲得標準治療的挑戰。

醫療機構面臨的經濟挑戰因不完善的報銷政策而進一步加劇，這些政策無法充分補償醫療服務提供者不斷成長的營運成本。複雜手術報銷額的降低使得醫療服務提供者難以維持先進的手術設施或投資新興技術。據美國醫學會稱，2024年醫療保險醫師費用表轉換係數將降低3.37%，這將加重進行脊椎介入手術的醫師的經濟負擔。這些報銷額的降低阻礙了必要治療方法的普及，並減少了願意進行這些擇期手術的專科醫生數量，從而抑制了整個行業的成長。

市場趨勢

隨著外科醫生越來越傾向於選擇與傳統光滑聚合物植入植入相比具有更優異骨整合性能的植入，業界正經歷著從PEEK材質到3D列印鈦合金頸椎融合器的重大轉變。積層製造技術能夠生產高度多孔的鈦合金結構，模擬鬆質骨的結構，從而有助於在頸椎前路切除術切除融合術（ACDF）中早期實現生物固定和穩定性。這項技術進步正在改變製造商的產品系列，並為該領域帶來顯著的收入成長。例如，史賽克公司於2024年10月發布的「2024年第三季營運業績」顯示，整形外科和脊椎業務部門的淨銷售額成長了10.7%。這一業績成長主要得益於市場對該公司先進的生物工程脊椎移植技術的持續需求。

同時，在支付方節約成本策略和微創技術日益精進的推動下，頸椎手術門診手術中心（ASC）的興起正在從根本上改變醫療服務的模式。隨著頸椎減壓和全人工椎間盤置換術效率的提高，患者數量正迅速從昂貴的住院治療轉向能夠更快出院的專業門診機構。這種結構性轉變體現在這些機構高風險病例的激增。根據果凍 Partners 於 2024 年 11 月發布的“2024 年第三季度財報電話會議”，該公司旗下機構的全關節置換術和高危險關節置換術量同比成長超過 50%，表明門診環境下複雜的整形外科和脊柱護理模式正被越來越多的人接受。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球頸椎病診斷與治療市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過診斷（影像檢查、頸部X光片、MRI、CT造影、神經功能檢查、肌電圖、神經傳導檢查）
    • 依產品類型（藥品、醫療設備、手術器材）
    • 按分銷管道（醫院藥房、零售藥房、網路藥房）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美頸椎病診斷與治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲頸椎病診斷與治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區頸椎病變診斷與治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲頸椎病診斷和治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲頸椎病診斷與治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球頸椎病變診斷與治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27676

The Global Cervical Spondylosis Diagnosis And Treatment Market is projected to expand from USD 6.44 Billion in 2025 to USD 9.51 Billion by 2031, registering a CAGR of 6.71%. This sector encompasses the medical identification and management of degenerative cervical spine changes through advanced imaging and therapeutic interventions designed to treat disk and joint deterioration. Growth is largely propelled by a rapidly aging global population and a rising incidence of lifestyle-induced neck disorders, creating a strong need for effective pain management and restorative care. Additionally, the focus on early detection to avert permanent neurological damage reinforces market expansion. As reported by the Global Alliance for Musculoskeletal Health in 2024, neck pain affected approximately 203 million people worldwide, with this figure expected to reach 269 million by 2050 due to shifting demographics.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.44 Billion
Market Size 2031USD 9.51 Billion
CAGR 2026-20316.71%
Fastest Growing SegmentRetail Pharmacies
Largest MarketNorth America

Despite promising growth prospects, the market faces significant hurdles due to the high costs of advanced diagnostic technologies and surgical procedures, which restrict access for patients in cost-sensitive areas. This financial obstacle is frequently compounded by insufficient reimbursement policies for elective spinal surgeries and a scarcity of qualified spine specialists in developing countries. These factors collectively limit the widespread adoption of premium treatment options, preventing broader market penetration in regions where healthcare resources are constrained.

Market Driver

The rapid growth of the global geriatric population and increasing life expectancy act as primary drivers for the market, directly elevating the number of patients prone to degenerative spinal issues. As people age, natural wear and tear on the cervical spine results in disk deterioration and osteophyte formation, requiring medical attention. According to a May 2025 report by StatPearls Publishing on 'Cervical Spondylosis,' the condition is viewed as a natural aging process with a 95% prevalence rate in individuals by age 65, ensuring steady demand for care. This trend is further supported by the United Nations' 'World Population Prospects 2024' report from July 2024, which noted that the global population aged 65 and older reached 830 million in 2024 and is expected to double to 1.7 billion by 2054, confirming the expanding scale of the patient base.

Concurrently, technological progress in diagnostic imaging and minimally invasive spinal surgeries is fueling market growth by improving treatment accuracy and patient safety. Innovations like robotic-assisted navigation and advanced MRI techniques enable precise interventions, which significantly lower surgical risks and recovery periods compared to conventional open surgeries, encouraging patients to choose restorative procedures previously considered too invasive. For example, an article in Becker's Spine Review from September 2024 titled 'Globus Medical's spine robot: 5 things to know' highlighted that Globus Medical saw a 59% year-over-year rise in robot unit placements during the second quarter. These advancements enhance patient outcomes and drive industry revenue by stimulating the adoption of premium, high-tech solutions.

Market Challenge

The high costs associated with advanced diagnostic technologies and surgical interventions represent a major obstacle to the growth of the cervical spondylosis diagnosis and treatment market. The substantial capital required for imaging equipment such as MRI and CT scanners, along with the expense of spinal implants and instrumentation, results in pricing that is often unaffordable in price-sensitive regions. This financial strain limits the patient base to individuals with considerable private funds or extensive insurance coverage, effectively excluding a significant demographic that needs treatment for degenerative neck conditions. As a result, the uptake of premium therapies is largely confined to developed economies, while lower-income markets encounter difficulties in accessing standard care.

This economic difficulty is exacerbated by inadequate reimbursement policies that do not sufficiently offset the rising operational expenses of medical practices. When compensation for complex procedures decreases, healthcare providers struggle to sustain advanced surgical facilities or invest in emerging technologies. According to the American Medical Association, the Medicare Physician Fee Schedule conversion factor was cut by 3.37 percent in 2024, intensifying the financial strain on physicians who perform spinal interventions. Such reimbursement reductions deter the widespread adoption of essential surgical solutions and reduce the number of specialists willing to undertake these elective procedures, thereby hindering the overall growth of the sector.

Market Trends

The industry is witnessing a significant shift from PEEK to 3D-Printed Titanium Cervical Cages, as surgeons increasingly favor implants that provide better osseointegration compared to traditional smooth polymers. Additive manufacturing allows for the production of highly porous titanium structures that replicate cancellous bone architecture, facilitating quicker biological fixation and stability during anterior cervical discectomy and fusion (ACDF) surgeries. This technological advancement is transforming manufacturer portfolios and generating substantial revenue growth in the segment. For instance, Stryker's 'Third Quarter 2024 Operating Results' from October 2024 revealed a 10.7% increase in net sales within their Orthopaedics and Spine segment, a performance attributed to the persistent demand for their advanced bio-engineered spinal implant technologies.

Simultaneously, the rise of Ambulatory Surgical Centers (ASCs) for cervical procedures is fundamentally changing the site-of-care landscape, influenced by payer cost-reduction strategies and the refinement of minimally invasive techniques. As cervical decompression and disc replacement surgeries become more efficient, patient volume is rapidly moving from expensive inpatient hospital departments to specialized outpatient facilities that provide faster discharge. This structural transition is evidenced by the surge in high-acuity cases within these settings. According to the 'Third Quarter 2024 Earnings Call' by Surgery Partners in November 2024, case volumes for total joint and high-acuity replacements in their facilities grew by over 50% year-over-year, underscoring the increasing acceptance of complex orthopedic and spinal care models in the ambulatory environment.

Key Market Players

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

Report Scope

In this report, the Global Cervical Spondylosis Diagnosis And Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cervical Spondylosis Diagnosis And Treatment Market, By Diagnosis

  • Imaging Tests
  • Neck X-ray
  • MRI
  • CT Myelography
  • Nerve Function Tests
  • Electromyography
  • Nerve Conduction Study

Cervical Spondylosis Diagnosis And Treatment Market, By Product Type

  • Medications
  • Medical Devices
  • Surgical Instruments

Cervical Spondylosis Diagnosis And Treatment Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Cervical Spondylosis Diagnosis And Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cervical Spondylosis Diagnosis And Treatment Market.

Available Customizations:

Global Cervical Spondylosis Diagnosis And Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, Nerve Conduction Study)
    • 5.2.2. By Product Type (Medications, Medical Devices, Surgical Instruments)
    • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Diagnosis
    • 6.2.2. By Product Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Diagnosis
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Diagnosis
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Diagnosis
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Diagnosis
    • 7.2.2. By Product Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Diagnosis
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Diagnosis
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Diagnosis
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Diagnosis
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Diagnosis
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Diagnosis
    • 8.2.2. By Product Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Diagnosis
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Diagnosis
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Diagnosis
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Diagnosis
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Diagnosis
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Diagnosis
    • 9.2.2. By Product Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Diagnosis
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Diagnosis
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Diagnosis
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Distribution Channel

10. South America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Diagnosis
    • 10.2.2. By Product Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Diagnosis
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Diagnosis
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Diagnosis
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cervical Spondylosis Diagnosis And Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Novartis AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck & Co. Inc.
  • 15.3. Bayer AG
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Ortho Bracing
  • 15.6. Medtronic Plc
  • 15.7. Stryker Corporation
  • 15.8. B. Braun SE
  • 15.9. DJO, LLC
  • 15.10. Aspen Medical Products, LLC

16. Strategic Recommendations

17. About Us & Disclaimer